Brief: Clinuvel Pharmaceuticals Declares Fully Franked Final Dividend Of A$0.04 Per Share
30/08/2022 06:39
Aug 30 (Reuters) - Clinuvel Pharmaceuticals Ltd CUV.AX :
* FULLY FRANKED FINAL DIVIDEND OF A$0.04 PER ORDINARY SHARE
HAS
BEEN DECLARED
* FY NET PROFIT ATTRIBUTABLE A$20.9 MILLION
* FY REVENUES FROM ORDINARY ACTIVITIES A$65.7 MILLION UP
37%
Source text for Eikon: ID:nASX9nPhpP
Further company coverage: CUV.AX
Recent news on Clinuvel Pharmaceuticals
See all newsBrief: Clinuvel Pharmaceuticals Announces Strategic Reorganisation To Refocus On U.S. Markets
Brief: Clinuvel Pharmaceuticals Ltd's ADS To Commence Trading On Nasdaq
Brief: Clinuvel Pharmaceuticals Says Scenesse Approved For EPP In Canada
Australia's Clinuvel Pharmaceuticals rises on Canada nod for phototoxicity prevention drug
Brief: Clinuvel Pharmaceuticals Updates On Level II ADR Upgrade, Nasdaq Uplist